ArticlePloS one2019

Utility of Ki67 labeling index, cyclin D1 expression, and ER-activity level in postmenopausal ER-positive and HER2-negative breast cancer with neoadjuvant chemo-endocrine therapy.

Sasagu Kurozumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.